The successful inclusion of ADA SCID in Tuscany expanded newborn screening program-Reference-Cited by-同舟云学术

The successful inclusion of ADA SCID in Tuscany expanded newborn screening program

Published:2021-05-06 Issue:10 Volume:59 Page:e401-e404
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:en
Short-container-title:

Author:

Malvagia Sabrina¹,Funghini Silvia¹,Della Bona Maria¹,Ombrone Daniela¹,Mura Massimo¹,Damiano Roberta¹,Ricci Silvia²³,Cortimiglia Martina²,Azzari Chiara²³,la Marca Giancarlo¹⁴^ORCID

Affiliation:

1. Newborn Screening, Clinical Chemistry and Pharmacology Lab , Meyer Children’s University Hospital , Florence , Italy

2. Immunology Unit , Meyer Children’s University Hospital , Florence , Italy

3. Department of Health Sciences , University of Florence , Florence , Italy

4. Department of Experimental and Clinical Biomedical Sciences , University of Florence , Florence , Italy

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry, medical,Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2021-0307/pdf

Reference12 articles.

1. Speckmann, C, Neumann, C, Borte, S, la Marca, G, Sass, JO, Wiech, E, et al.. Delayed-onset adenosine deaminase deficiency: strategies for an early diagnosis. J Allergy Clin Immunol 2012;130:991–4. https://doi.org/10.1016/j.jaci.2012.04.004.

2. Hershfield, MS, Mitchell, BS. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In: Scriver, CR, AL Beaudet, WS S, Valle, D, editors. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw-Hill; 1995:1725–68 pp.

3. Verbsky, JW, Baker, MW, Grossman, WJ, Hintermeyer, M, Dasu, T, Bonacci, B, et al.. Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008–2011). J Clin Immunol 2012;32:82–8. https://doi.org/10.1007/s10875-011-9609-4.

4. Gaspar, HB, Hammarström, L, Mahlaoui, N, Borte, M, Borte, S. The case for mandatory newborn screening for severe combined immunodeficiency (SCID). J Clin Immunol 2014;34:393–7. https://doi.org/10.1007/s10875-014-0029-0.

5. Chan, K, Davis, J, Pai, SY, Bonilla, FA, Puck, JM, Apkon, M. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metabol 2011;104:383–9. https://doi.org/10.1016/j.ymgme.2011.07.007.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Very Early Diagnosis of Complete Androgen Insensitivity Syndrome Due to a Novel Variant in the AR Gene: A Neonatal Case Study;Biomedicines;2024-08-02

2. Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023);International Journal of Neonatal Screening;2024-05-23

3. Difetti congeniti dell’immunità: non solo le vecchie immunodeficienze;Medico e Bambino;2024-04-24

4. Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency;Nature Medicine;2024-02

5. Newborn screening for severe combined immunodeficiencies (SCID) in Germany;Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz;2023-09-19